{
    "clinical_study": {
        "@rank": "119463", 
        "acronym": "RISQ-PATH", 
        "arm_group": {
            "arm_group_label": "patients with delirium"
        }, 
        "biospec_descr": {
            "textblock": "-  1 blood sample (whole blood) to measure the blood concentration of haloperidol\n\n        -  1 blood sample (DNA) to store in a biobank for additional research"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "A prospective, observational study in a general hospital (UZ Leuven). Patients with delirium\n      are included when they are treated with haloperidol. An ECG is taken before the\n      administration of haloperidol and 3-5 days after starting haloperidol to investigate the\n      change in duration of the QTc-interval. Risk factors for developing QT-prolongation will be\n      documented. Together with ECG2, an additional blood sample will be collected to measure the\n      blood concentration of haloperidol."
        }, 
        "brief_title": "Risk of QT-prolongation and Torsade de Pointes in Delirium Patients Treated With Haloperidol", 
        "condition": [
            "Delirium", 
            "QT-prolongation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Delirium", 
                "Torsades de Pointes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  treatment with haloperidol (indication: delirium)\n\n          -  inpatient of UZ Leuven, admitted on one of the participating wards\n\n        Exclusion Criteria:\n\n          -  < 18 years old\n\n          -  DNR-code 2 or 3\n\n          -  not possible to take an ECG before the start of haloperidol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with delirium treated with haloperidol. In a general hospital."
            }
        }, 
        "enrollment": {
            "#text": "175", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02068170", 
            "org_study_id": "EV003"
        }, 
        "intervention": {
            "arm_group_label": "patients with delirium", 
            "intervention_name": "Haloperidol", 
            "intervention_type": "Drug", 
            "other_name": "Haldol, ATC-code: N05AD01"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Haloperidol", 
                "Haloperidol decanoate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "QT-prolongation", 
            "Torsade de Pointes", 
            "haloperidol", 
            "delirium"
        ], 
        "lastchanged_date": "February 19, 2014", 
        "location": {
            "contact": {
                "email": "eline.vandael@pharm.kuleuven.be", 
                "last_name": "Eline Vandael, PhD-student", 
                "phone": "+32 16 379583"
            }, 
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "zip": "3000"
                }, 
                "name": "UZ Leuven"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_groups": "1", 
        "official_title": "Risk of QT-prolongation and Torsade de Pointes in Delirium Patients Treated With Haloperidol", 
        "overall_contact": {
            "email": "eline.vandael@pharm.kuleuven.be", 
            "last_name": "Eline Vandael, PhD-student", 
            "phone": "+32 16 379583"
        }, 
        "overall_contact_backup": {
            "email": "veerle.foulon@pharm.kuleuven.be", 
            "last_name": "Veerle Foulon, Prof."
        }, 
        "overall_official": {
            "affiliation": "Katholieke Universiteit Leuven", 
            "last_name": "Eline Vandael, PhD-student", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "change in QTc-interval (corrected for heart rate)", 
            "safety_issue": "Yes", 
            "time_frame": "before and 3-5 days after the start of haloperidol"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02068170"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Katholieke Universiteit Leuven", 
            "investigator_full_name": "Eline Vandael", 
            "investigator_title": "PhD-student", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Katholieke Universiteit Leuven", 
        "sponsors": {
            "collaborator": {
                "agency": "Agentschap voor Innovatie door Wetenschap en Technologie", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Katholieke Universiteit Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}